康希诺生物 CanSinoBIO

Keywords you search：

1 VOLUNTARY ANNOUNCEMENT INITIATION OF PHASE I CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT FOR ABSORBED TETANUS VACCINE

Description
2 Monthly Return of Equity Issuer on Movements in Securities

Description
3 Letter to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form

Description
4 Letter to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form

Description
5 VOLUNTARY ANNOUNCEMENT INITIATION OF PHASE I CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT FOR RECOMBINANT POLIOMYELITIS VACCINE

Description
6 PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND RULES OF PROCEDURES

Description
7 TERMS OF REFERENCE OF THE AUDIT COMMITTEE OF THE BOARD

Description
8 TERMS OF REFERENCE FOR THE NOMINATION COMMITTEE OF THE BOARD

Description
9 TERMS OF REFERENCE FOR THE REMUNERATION AND ASSESSMENT COMMITTEE OF THE BOARD

Description
10 NOTICE OF THE 2024 FIRST EXTRAORDINARY GENERAL MEETING

Description

First Page Pre. Page Current Page(56) Next Page End Page(63)